Hypnion

About:

Hypnion is a neuroscience drug discovery company.

Top Investors: Alexandria Real Estate Equities, SR One, JAFCO, JAFCO Asia, MPM Capital

Description:

Hypnion is a neuroscience drug discovery and development company that develops novel therapeutics for the treatment of central nervous system disorders. The company develops treatments for sleep- and wake-alertness disorders and circadian rhythm abnormalities. Hypnion offers SCORE-2004, a drug discovery platform that is able to measure drugs’ impact on sleep and wake parameters. Hypnion is acquired by Eli Lilly and Company. Hypnion was founded in 2000 and is based in Worcester, Massachusetts.

Total Funding Amount:

$78M

Headquarters Location:

Lexington, Massachusetts, United States

Founded Date:

2000-01-01

Founders:

Number of Employees:

51-100

Last Funding Date:

2005-12-19

IPO Status:

Private

Industries: